I-Mab Gets Boost from Latest Industry Signals on New Cancer Treatment 癌癥新療法取得突破，力推天境生物股價上漲
Company’s shares surged as much as 15% after AstraZeneca unveiled upbeat results for a new class of cancer drugs known as CD73 antibodies 在阿斯利康宣布CD73抗體的新型抗癌藥物取得樂觀結(jié)果后，天境生物的股價飆升15%。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.